There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oncternal Therapeutics (ONCT – Research Report), Allena Pharmaceuticals (ALNA – Research Report) and Gritstone Oncology (GRTS – Research Report) with bullish sentiments. Oncternal Therapeutics (ONCT) H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Oncternal Therapeutics today and set a price target of $9.00. The company's shares closed last Tuesday at $2.34. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oncternal-therapeutics-onct-allena-pharmaceuticals-alna-and-gritstone-oncology-grts?utm_source=advfn.com&utm_medium=referral
Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Oncternal Therapeutics Charts.
Oncternal Therapeutics (NASDAQ:ONCT)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Oncternal Therapeutics Charts.